Page last updated: 2024-08-18

cyclohexanol and tyramine

cyclohexanol has been researched along with tyramine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Rekharsky, MV; Ross, PD1
Béïque, JC; Blier, P; de Montigny, C; Debonnel, G1
Ishiwa-Chigusa, S; Komatsu, A; Kutsukake, M; Yamamoto, D1
Harvey, AT; Preskorn, SH; Rudolph, RL1
Blier, P; de Montigny, C; Debonnel, G; Hébert, C; Lavoie, N; Saint-André, E2
Feliszek, M; Ilayan, E; Malinowska, B; Schlicker, E1
Aldosary, F; Blier, P; James, JS; Norris, S; Ritchie, JC; Tremblay, P1

Trials

2 trial(s) available for cyclohexanol and tyramine

ArticleYear
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Blood Pressure; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Piperazines; Reference Values; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Triazoles; Tyramine; Venlafaxine Hydrochloride

2007
Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Time Factors; Treatment Outcome; Tyramine; Venlafaxine Hydrochloride

2007

Other Studies

6 other study(ies) available for cyclohexanol and tyramine

ArticleYear
Thermodynamics of hydrogen bond and hydrophobic interactions in cyclodextrin complexes.
    Biophysical journal, 1996, Volume: 71, Issue:4

    Topics: Amines; Calorimetry; Carbohydrate Conformation; Crystallography, X-Ray; Cyclodextrins; Cyclohexanols; Hydrogen Bonding; Ligands; Phenethylamines; Phenylbutyrates; Phenylpropionates; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Thermodynamics; Tyramine

1996
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Synapse (New York, N.Y.), 1999, Jun-01, Volume: 32, Issue:3

    Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Binding Sites; Cyclohexanols; Desipramine; Fenfluramine; Hippocampus; In Vitro Techniques; Locus Coeruleus; Male; Neurons; Norepinephrine; Paroxetine; Piperazines; Piperoxan; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Tyramine; Venlafaxine Hydrochloride

1999
A tyramine receptor gene mutation causes a defective olfactory behavior in Drosophila melanogaster.
    Gene, 2000, Mar-07, Volume: 245, Issue:1

    Topics: Acetates; Animals; Behavior, Animal; Benzaldehydes; Central Nervous System; Cyclohexanols; DNA Transposable Elements; Dose-Response Relationship, Drug; Drosophila melanogaster; Electrophysiology; Enhancer Elements, Genetic; Exons; Gene Expression Regulation, Developmental; Genes; Introns; Larva; Muscles; Mutagenesis, Insertional; Mutation; Octopamine; Olfactory Pathways; Receptors, Biogenic Amine; Tyramine

2000
Evidence of the dual mechanisms of action of venlafaxine.
    Archives of general psychiatry, 2000, Volume: 57, Issue:5

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Biological Transport, Active; Blood Platelets; Blood Pressure; Cyclohexanols; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Male; Maprotiline; Middle Aged; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Systole; Tyramine; Venlafaxine Hydrochloride

2000
Do cannabinoids exhibit a tyramine-like effect?
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Animals; Arachidonic Acids; Benzoxazines; Cannabidiol; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Glycerides; Kidney Cortex; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Time Factors; Tyramine

2013
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
    The international journal of neuropsychopharmacology, 2022, 04-19, Volume: 25, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Cyclohexanols; Depressive Disorder, Major; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tyramine; Venlafaxine Hydrochloride

2022